Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules

Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules

Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent ethyl acid soft gel capsules to the market. This new product, referencing VASCEPA®, is set to be commercialized by Amneal starting in the fourth quarter of 2023. The in-licensing of this product from Strides, a global pharmaceutical […]